Brief: Humanigen And Cenexi Announce Collaboration To Manufacture Lenzilumab In France

Humanigen

09/02/2022 04:57

Feb 8 (Reuters) - Humanigen Inc  HGEN.O :
    * HUMANIGEN AND CENEXI ANNOUNCE COLLABORATION TO MANUFACTURE
LENZILUMAB IN FRANCE
    * HUMANIGEN AND CENEXI WILL ENTER INTO DISCUSSIONS TO
POTENTIALLY
EXPAND AGREEMENT TO OTHER SERVICES CENEXI OFFERS
    * CENEXI TO BECOME PREFERRED DRUG PRODUCT SUPPLIER FOR
FRANCE AND
EUROPEAN UNION
    * HUMANIGEN PLANS TO FILE A REQUEST FOR AAP WITH HAUTE
AUTHORITE
DE SANTE IN FEBRUARY 2022
    * PLANS TO INCLUDE CENEXI NORMANDY SITE IN CERTAIN OF ITS
FUTURE
REGULATORY FILINGS FOR LENZILUMAB FOR COVID-19 AND OTHER
INDICATIONS
    * HUMANIGEN - PENDING POSITIVE RESULTS FROM NIH-SPONSORED
ACTIV-5/BET-B STUDY, CO PLANS TO AMEND EMERGENCY USE
AUTHORIZATION APPLICATION IN UNITED STATES

Source text for Eikon:  ID:nBw2kNscca 
Further company coverage:  HGEN.O 

 ((Reuters.Briefs@thomsonreuters.com;))